Gyre Therapeutics Inc Revenue per Employee (GYRE), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Gyre Therapeutics Inc   (NASDAQ: GYRE)
 

Gyre Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 8.72% in the second quarter 2026, year on year to cumulative value of $119 million, Gyre Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 193,176, this marks a new company high.
Within the Healthcare sector Employees of 396 other companies have achieved higher revenue per employee. While Gyre Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 2781 to 3001. Gyre Therapeutics Inc has 618 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GYRE Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 8.72 % 2.09 % 33.45 % 19.92 % 6.13 %
Sales per Employee (TTM) $ 193,176 189,400 188,654 173,568 165,354
GYRE's Total Ranking # 3001 # 2781 # 150 # 140 # 170
Seq. Revenue Change 29.25 % -39.46 % 21.7 % 14.17 % 21.37 %

GYRE Company Profile >> Back to GYRE Efficiency Comparisons >> Compare GYRE Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 149
Healthcare Sector # 397
Overall Market # 3001

Revenue per Employee Statistics
High Average Low
$ 193,176 $ 57,755 $ 353
(Jun 30 2026)   (Sep 30 2016)



Financial Statements
Gyre Therapeutics Inc 's Revenue MRQ $ 29 Millions Visit GYRE's Income Statement
Gyre Therapeutics Inc 's Revenues TTM $ 119 Millions Visit GYRE's aggregate revenue growth
What are GYRE's Sales? Visit GYRE's Sales by Segment




Other Ratios
Gyre Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
GYRE's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for GYRE's Competitors
Revenue per Employee for GYRE's Suppliers
Revenue per Employee for GYRE's Customers

You may also want to know
GYRE's Sales Growth Rates GYRE's Pe Price to earnings ratio GYRE's Receivables Turnover Ratio GYRE's Stock Quote
GYRE's Net Income Growth Rates GYRE's Ps Price to Sales ratio GYRE's Sales per Employee GYRE's Asset Turnover Ratio
GYRE's Net Margin GYRE's Pb Price to Book ratio GYRE's Financial Strength Ratios GYRE's Dividend Payout Ratio
Date modified: 2026-08-14T20:17:45+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
C4 Therapeutics Inc   336,913.46 $ 35.039  Million 104 
Omada Health Inc   336,730.35 $ 308.445  Million 916 
Cumberland Pharmaceuticals Inc   336,223.53 $ 31.269  Million 93 
Avita Medical Inc   334,650.44 $ 75.631  Million 226 
Sutro Biopharma Inc   333,591.24 $ 45.702  Million 137 
Gossamer Bio Inc   328,925.93 $ 53.286  Million 162 
Pacific Biosciences Of California Inc   328,484.54 $ 159.315  Million 485 
Exagen Inc   324,668.18 $ 71.427  Million 220 
Intelligent Bio Solutions Inc   324,244.23 $ 4.215  Million 13 
Quanterix Corporation  324,237.79 $ 152.716  Million 471 
Nutriband Inc   323,536.00 $ 1.618  Million 5 
Tactile Systems Technology Inc   322,577.35 $ 350.319  Million 1,086 
Ceribell Inc   311,327.22 $ 101.804  Million 327 
Bionano Genomics Inc   311,092.78 $ 30.176  Million 97 
West Pharmaceutical Services Inc   308,046.30 $ 3,326.900  Million 10,800 
Beam Therapeutics Inc   305,352.25 $ 156.035  Million 511 
Sensus Healthcare Inc   304,900.00 $ 18.294  Million 60 
Infusystem Holdings Inc  303,033.83 $ 143.335  Million 473 
Myriad Genetics Inc   298,481.48 $ 805.900  Million 2,700 
Pediatrix Medical Group Inc   297,578.18 $ 1,950.625  Million 6,555 
Kura Oncology Inc   297,019.23 $ 77.225  Million 260 
Adapthealth Corp   296,028.35 $ 3,226.709  Million 10,900 
Pulmonx Corporation  295,246.62 $ 87.393  Million 296 
International Stem Cell Corporation  288,303.03 $ 9.514  Million 33 
Radnet Inc   288,228.15 $ 2,268.932  Million 7,872 
Beta Bionics Inc   284,554.76 $ 119.513  Million 420 
Vaso Corporation  284,468.09 $ 80.220  Million 282 
Prelude Therapeutics Inc  283,848.10 $ 22.424  Million 79 
Cv Sciences Inc   274,227.27 $ 12.066  Million 44 
Cvrx inc   269,793.72 $ 60.164  Million 223 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.